An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2010-09-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10549-009-0674-9PMID 20020197
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genes that mediate breast cancer metastasis to the brain

  2009cited by this paper
• The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy

  2009cited by this paper
• Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patients

  2009cited by this paper
• Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue.

  2009cited by this paper
• Evaluation of Microarray Preprocessing Algorithms Based on Concordance with RT-PCR in Clinical Samples

  2009cited by this paper
• The removal of multiplicative, systematic bias allows integration of breast cancer gene expression datasets – improving meta-analysis and prediction of prognosis

  2008cited by this paper
• Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen

  2008cited by this paper
• The humoral immune system has a key prognostic impact in node-negative breast cancer.

  2008cited by this paper
• American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

  2007cited by this paper
• American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer.

  2007cited by this paper
• Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients

  2007cited by this paper
• Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series

  2007cited by this paper
• Lung metastasis genes couple breast tumor size and metastatic spread

  2007cited by this paper
• Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade.

  2007cited by this paper
• Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study.

  2007cited by this paper
• Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.

  2006cited by this paper
• Reliability and reproducibility issues in DNA microarray measurements.

  2006cited by this paper
• Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer.

  2006cited by this paper
• Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

  2006cited by this paper
• The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

  2006cited by this paper
• Population-based validation of the prognostic model ADJUVANT! for early breast cancer.

  2005cited by this paper
• An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival.

  2005cited by this paper
• Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.

  2005cited by this paper
• Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?

  2005cited by this paper
• Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

  2005cited by this paper
• affy - analysis of Affymetrix GeneChip data at the probe level

  2004cited by this paper
• A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

  2004cited by this paper
• Evaluation of gene expression measurements from commercial microarray platforms.

  2003cited by this paper
• Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.

  2003cited by this paper
• Scarff-Bloom-Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy.

  2002cited by this paper
• Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer.

  2001influential reference
• Estrogen receptor analysis in primary breast tumors by ligand-binding assay, immunocytochemical assay, and northern blot: a comparison

  2001cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Bmc Medical Genomics the Gene Expression Grade Index: a Potential Predictor of Relapse for Endocrine-treated Breast Cancer Patients in the Big 1–98 Trial

  year unknowncited by this paper

• EsurvFusion: An Evidential Multimodal Survival Fusion Model Based on Epistemic Random Fuzzy Sets

  2026cites this paper
• Overexpression of TFF3 is Associated with Immune Infiltration, Molecular Subtypes, and Clinical Progression in Breast Cancer.

  2026cites this paper
• Monocyte reprogramming by nociceptors impedes T cell-mediated tumor immunity

  2026cites this paper
• Comprehensive characterization of AP-1 adaptor complex genes in lung cancer reveals AP1AR as a novel prognostic and therapeutic biomarker

  2026cites this paper
• Inhibition of IRE1α kinase increases ferroptosis resistance in triple-negative breast cancer cells.

  2026cites this paper
• A comprehensive analysis identified BECN1 as potential diagnostic biomarker for homotypic cell-in-cell in non-small cell lung cancer through integrated bioinformatics and clinical validation approaches

  2026cites this paper
• Histone methyltransferase SMYD1: playing a crucial role in disease progression.

  2026cites this paper
• Differential responses to the combination of navitoclax and venetoclax with doxorubicin in murine models of triple negative breast cancer.

  2026cites this paper
• Repression of Polycomb Group Factor 1 Inhibits EMT Progression in Colon Cancers Cells via Wnt/β-Catenin and PI3K/Akt/mTOR Signaling Pathway.

  2026cites this paper
• AMIGO2 as a Novel Biomarker Predicting Poor Prognosis and Associated with Adhesion-Driven Metastasis in Pancreatic Adenocarcinoma

  2026cites this paper
• Does the B7-H3 Immune Checkpoint Have High Potential as a Therapeutic Target?

  2026cites this paper
• ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

  2025cites this paper
• Oncogenic role of fumarate hydratase in breast cancer: metabolic reprogramming and mechanistic insights

  2025cites this paper
• CXCR4+ mammary gland macrophageal niche promotes tumor initiating cell activity and immune suppression during tumorigenesis

  2025cites this paper
• Resveratrol Downregulated PRDX4 Expression to Inhibit the Progression of Renal Cell Carcinoma via Wnt/β‐Catenin Pathway

  2025cites this paper
• JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer

  2025cites this paper
• ATPase copper transporting beta attenuates malignant features with high expression as an indicator of favorable prognosis in breast cancer

  2025cites this paper
• Keratin 24 Predicts Poor Prognosis in Breast Cancer

  2025cites this paper
• БІОІНФОРМАТИЧНИЙ АНАЛІЗ КЛЮЧОВИХ ФАКТОРІВ РЕГУЛЯЦІЇ ЕКСПРЕСІЇ ЕЛАСТИНУ В УМОВНО НОРМАЛЬНІЙ ТА ЗЛОЯКІСНО ТРАНСФОРМОВАНІЙ ТКАНИНІ МОЛОЧНОЇ ЗАЛОЗИ

  2025cites this paper
• LSD1 engaged ERα activation orchestrates the formation of migrasomes to promote gastric cancer metastasis.

  2025cites this paper
• Evaluation of Metaplastic Triple-Negative Breast Cancer Extracellular Matrix Structure and Protein Composition

  2025cites this paper
• Serum chemerin levels and the risk of muscle health decline in geriatric population

  2025cites this paper
• Impact pathway and gene ontology analyses of FOXC2 ‐correlated genes in melanoma reveal a role for the FOXC2 transcription factor in several oncogenic pathways and processes

  2025cites this paper
• Integrated Analysis of Bulk and Single-Cell Transcriptomics Identifies Prognostic Biomarkers in Breast Cancer Metastasis.

  2025cites this paper
• Twist1 silencing suppresses triple-negative breast cancer progression by reducing RNF40 transcription

  2025cites this paper
• TIM3-blockade synergizes with IL2 in alleviating intra-tumoral CD8+T cell exhaustion

  2025cites this paper
• Semaphorin 3F inhibits breast cancer metastasis by regulating the Akt-mTOR and TGFβ signaling pathways via neuropilin-2

  2025cites this paper
• Oxytocin receptor and HER2 interactions in breast cancer

  2025cites this paper
• Nicotine‐driven enhancement of tumor malignancy in triple‐negative breast cancer via additive regulation of CHRNA9 and IGF1R

  2025cites this paper
• OTUD3 inhibits breast cancer cell metastasis by regulating TGF-β pathway through deubiquitinating SMAD7

  2025cites this paper
• Bile Acid Receptor FXR Agonism with Ocaliva Reduces Tumor Burden and MYC Signaling in Preclinical TNBC

  2025cites this paper
• BGN Secreted by Cancer-Associated Fibroblasts Promotes Esophageal Squamous Cell Carcinoma Progression via Activation of TLR4-Mediated Erk and NF-κB Signaling Pathways

  2025cites this paper
• CXCR4 expression serves as a promising candidate target in the treatment of breast cancer

  2025cites this paper
• DualMarker: A Multi-Source Fusion Identification Method for Prognostic Biomarkers of Breast Cancer Based on Dual-Layer Heterogeneous Network

  2025cites this paper
• Discovery of Prognostic Biomarkers in Gastric Cancer Through Machine Learning and Bioinformatics Analysis of Gene Expression Data

  2025cites this paper
• TMEM176A drives anti-apoptotic signaling through TGM2-mediated ERK activation in gastric cancer.

  2025cites this paper
• CCR5 expression and conformational stability as potential cooperative modulators of immune phenotypes and therapy response in breast cancer

  2025cites this paper
• A Chain-Based Batch Recombination in Stochastic Gradient Descent for Cox Proportional Hazards Models

  2025cites this paper
• PHLDA2 promotes breast cancer metastasis by co-opting a developmental program for placental vascular remodeling

  2025cites this paper
• Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancer

  2025cites this paper
• GATA Binding Protein 3 as a Diagnostic Biomarker and Immune Infiltrates Regulator in Stomach Adenocarcinoma

  2025cites this paper
• PHLPP1 depletion promotes tumorigenesis and stemness in triple-negative breast cancer cells through AKT signaling

  2025cites this paper
• Ghrelin-induced neuronal NPY promotes brain metastasis in lung cancer patients with low BMI

  2025cites this paper
• Gender-specific insights into TTN mutation: potential biomarker for female risk in kidney renal clear cell carcinoma

  2025cites this paper
• The Role of the Cell Surface Heparan Sulfate Proteoglycan Syndecan-3 in Breast Cancer Pathophysiology

  2025cites this paper
• Erianin ameliorates morphine tolerance and glioma progression through the JAK2-STAT3 pathway

  2025cites this paper
• Histone Lactylation Bridges Metabolic Reprogramming with Chromatin-Immune Crosstalk in Triple-Negative Breast Cancer.

  2025cites this paper
• The metabolic significance of ATP-citrate lyase in cancer: insights into glutamine-fuelled citrate biosynthesis and tumour progression

  2025cites this paper
• DAPL1 Identified as a Novel Prognostic Biomarker in Breast Cancer: Insights from Comprehensive in Silico Analysis

  2025influential citation
• Novel organoid-based exploration reveals the role of LMTK3/FADS2 signaling in metastatic breast cancer progression in felines and humans

  2025cites this paper
• Adaptive Proteomic Changes in Protein Metabolism and Mitochondrial Alterations Associated with Resistance to Trastuzumab and Pertuzumab Therapy in HER2-Positive Breast Cancer

  2025influential citation
• Exploring the interplay between LDHA and ABCC1 in breast cancer using computational approach

  2025cites this paper
• BLID is a drug-responsive target of FOXO3a and multi-omics analysis reveals survival mechanisms and therapeutic vulnerabilities in BLID-deficient breast cancer cells

  2025cites this paper
• Integrative analysis of mRNA stability regulation uncovers a metastasis-suppressive program in breast cancer

  2025cites this paper
• NUPR1 contributes to endocrine therapy resistance by modulating BIRC5 expression and inducing luminal B-ERBB2+ subtype-like characteristics in estrogen receptor-positive breast cancer cells

  2025cites this paper
• HOXA10‐AS Enhances Gastric Cancer Cell Proliferation, Migration, and Invasion via the p38 MAPK/STAT3 Signaling Pathway

  2025cites this paper
• Evidential time-to-event prediction with calibrated uncertainty quantification

  2025cites this paper
• Comprehensive identification of hub mRNAs and lncRNAs in colorectal cancer using galaxy: an in silico transcriptome analysis

  2025cites this paper
• A novel clinically relevant antagonistic interplay between prolactin and oncogenic YAP-CCN2 pathways as a differentiation therapeutic target in breast cancer

  2025cites this paper
• Potentials of peroxisome proliferator-activated receptor (PPAR) α, β/δ, and γ: An in-depth and comprehensive review of their molecular mechanisms, cellular Signalling, immune responses and therapeutic implications in multiple diseases.

  2025cites this paper
• Identification of novel therapeutic targets for head and neck squamous cell carcinoma through bioinformatics analysis

  2024cites this paper
• The therapeutic potential of RNA m(6)A in lung cancer

  2024cites this paper
• Adenylate cyclase 9 expression level is associated with hormone receptor-positive breast cancer and predicts patient prognosis

  2024cites this paper
• Integrative analysis of inhibitor of DNA-binding expression and prognosis in non-small cell lung cancer

  2024cites this paper
• A trafficking regulatory subnetwork governs αVβ6 integrin-HER2 cross-talk to control breast cancer invasion and drug resistance

  2024cites this paper
• Knockdown of NDUFAF6 inhibits breast cancer progression via promoting mitophagy and apoptosis

  2024cites this paper
• Targeted therapy for KIF3C: A study on the mechanism of combined therapy with KIF3C signaling pathway, afatinib, and MT-DC (ac)phosphoramide in regulating gastric cancer cell proliferation.

  2024cites this paper
• LATS2 and FAT4 as key candidate genes of hippo pathway associated with the risk and progression of breast cancer: an in-silico approach

  2024cites this paper
• Identification of Diagnostic and Prognostic Subnetwork Biomarkers for Women with Breast Cancer Using Integrative Genomic and Network-Based Analysis

  2024cites this paper
• Down-regulation of ESRP2 inhibits breast cancer cell proliferation via inhibiting cyclinD1

  2024cites this paper
• DSTYK Inhibition Sensitizes Non-Small Cell Lung Cancer To Taxane-Based Chemotherapy.

  2024cites this paper
• Exploring the Dynamic Interplay of Deleterious Variants on the RAF1–RAP1A Binding in Cancer: Conformational Analysis, Binding Free Energy, and Essential Dynamics

  2024cites this paper
• Cell division cycle 6 ​is an independent prognostic biomarker in breast cancer.

  2024cites this paper
• Roles of cathepsin S expression levels on the prognosis and tumour microenvironment in clear cell renal cell carcinoma

  2024cites this paper
• High Expression of ZNF208 Predicts Better Prognosis and Suppresses the Tumorigenesis of Breast Cancer

  2024cites this paper
• α-Parvin Expression in Breast Cancer Tissues: Correlation with Clinical Parameters and Prognostic Significance

  2024cites this paper
• Co-expression network and survival analysis of breast cancer inflammation and immune system hallmark genes

  2024cites this paper
• SON is an essential RNA splicing factor promoting ErbB2 and ErbB3 expression in breast cancer

  2024cites this paper
• Acyl-CoA Thioesterase 8 (ACOT8) is a Poor Prognostic Biomarker in Breast Cancer

  2024cites this paper
• The role of the ALKBH5 RNA demethylase in invasive breast cancer

  2024cites this paper
• Study of LY9 as a potential biomarker for prognosis and prediction of immunotherapy efficacy in lung adenocarcinoma

  2024cites this paper
• ACTL8 Promotes the Progression of Gastric Cancer Through PI3K/AKT/mTOR Signaling Pathway

  2024cites this paper
• Tumor suppressor KEAP1 promotes HSPA9 degradation, controlling mitochondrial biogenesis in breast cancer.

  2024cites this paper
• Overexpression of Extracellular Superoxide Dismutase 3 Inhibits Cancer Cell Growth and Migration in Colorectal Cancer

  2024cites this paper
• Prognostic and Therapeutic Implications of Cell Division Cycle 20 Homolog in Breast Cancer

  2024cites this paper
• NOTCH3 as a prognostic biomarker and its correlation with immune infiltration in gastrointestinal cancers

  2024cites this paper
• Identifying ribonucleotide reductase subunit genes as potential lung adenocarcinomas biomarkers using integrated bioinformatics analysis

  2024influential citation
• Towards key genes identification for breast cancer survival risk with neural network models

  2024cites this paper
• The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma

  2024cites this paper
• Expression profile and functional analysis of miR-301b in patients with breast cancer: A bioinformatics, biochemical, and histopathological study.

  2024cites this paper
• Density Gradient Centrifugation Is an Effective Tool to Isolate Cancer Stem-like Cells from Hypoxic and Normoxia Triple-Negative Breast Cancer Models

  2024cites this paper
• Elevated expression of Aurora-A/AURKA in breast cancer associates with younger age and aggressive features

  2024cites this paper
• Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain.

  2024cites this paper
• C1orf106 (INAVA) Is a SMAD3-Dependent TGF-β Target Gene That Promotes Clonogenicity and Correlates with Poor Prognosis in Breast Cancer

  2024cites this paper
• Glutathione and Xanthine Metabolic Changes in Tamoxifen Resistant Breast Cancer Cell Lines are Mediated by Down-Regulation of GSS and XDH and Correlated to Poor Prognosis

  2024cites this paper
• Comprehensive analysis of the prognostic value of glutathione S‐transferases Mu family members in breast cancer

  2024cites this paper
• Identification of significant hub genes and pathways associated with metastatic breast cancer and tolerogenic dendritic cell via bioinformatics analysis

  2024cites this paper
• Integrated single-cell analysis reveals distinct epigenetic-regulated cancer cell states and a heterogeneity-guided core signature in tamoxifen-resistant breast cancer

  2024cites this paper
• The tumor suppressor SALL2 opposes chemotherapeutic resistance in breast cancer

  2024cites this paper
• MAZ-mediated up-regulation of BCKDK reprograms glucose metabolism and promotes growth by regulating glucose-6-phosphate dehydrogenase stability in triple-negative breast cancer

  2024cites this paper